Estimates Revisions Lisata Therapeutics, Inc.
Stocks
LSTA
US1280583022
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.490 USD | +3.47% |
|
-0.67% | -19.89% |
| 09-17 | Lisata Therapeutics, Inc.(NasdaqCM:LSTA) added to NASDAQ Composite Index | CI |
| 09-17 | Lisata Therapeutics, Inc. (Nasdaq: LSTA) acquired Marea Therapeutics, Inc. for approximately $240 million. | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- LSTA Stock
- Consensus Lisata Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
